The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on the level of DNA damage in heterozygous familial hypercholesterolaemia (HEFH).

Saved in:
Bibliographic Details
Title: The effects of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on the level of DNA damage in heterozygous familial hypercholesterolaemia (HEFH).
Authors: Woźniak, E.1 (AUTHOR), Gorzelak-Pabiś, P.2 (AUTHOR), Woźniak, A.1 (AUTHOR), Pawlos, A.2 (AUTHOR), Bukowska, B.3 (AUTHOR), Broncel, M.2 (AUTHOR)
Source: Atherosclerosis (00219150). 2023 Supplement 1, Vol. 379, pS37-S38. 2p.
Database: Academic Search Ultimate
Description
ISSN:00219150
DOI:10.1016/j.atherosclerosis.2023.06.172